{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:11:07Z","timestamp":1789963867164,"version":"4.0.1"},"reference-count":218,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,2,1]]},"DOI":"10.1210\/me.2014-1316","type":"journal-article","created":{"date-parts":[[2014,12,30]],"date-time":"2014-12-30T16:43:12Z","timestamp":1419957792000},"page":"172-186","source":"Crossref","is-referenced-by-count":30,"title":["Minireview: Nuclear Receptor Regulation of Osteoclast and Bone Remodeling"],"prefix":"10.1210","volume":"29","author":[{"given":"Zixue","family":"Jin","sequence":"first","affiliation":[{"name":"Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas 75390"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas 75390"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihong","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas 75390"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041201353688000_B1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev.pathmechdis.3.121806.151431","article-title":"The osteoclast: friend or foe?","volume":"3","author":"Novack","year":"2008","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"2019041201353688000_B2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrrheum.2011.23","article-title":"Advances in osteoclast biology: old findings and new insights from mouse models","volume":"7","author":"Edwards","year":"2011","journal-title":"Nat Rev Rheumatol"},{"issue":"23","key":"2019041201353688000_B3","doi-asserted-by":"crossref","first-page":"13361","DOI":"10.1073\/pnas.95.23.13361","article-title":"Bone homeostasis","volume":"95","author":"Rodan","year":"1998","journal-title":"Proc Nat Acad Sci USA"},{"key":"2019041201353688000_B4","article-title":"Bone Health and Osteoporosis: A Report of the Surgeon General","author":"U.S. Department of Health and Human Services","year":"2004"},{"issue":"2","key":"2019041201353688000_B5","first-page":"115","article-title":"Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis","volume":"21","author":"Manolagas","year":"2000","journal-title":"Endocr Rev"},{"issue":"3","key":"2019041201353688000_B6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00002281-200005000-00006","article-title":"Pathogenesis of bone erosions in rheumatoid arthritis","volume":"12","author":"Goldring","year":"2000","journal-title":"Curr Opin Rheumatol"},{"issue":"9","key":"2019041201353688000_B7","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrendo.2013.137","article-title":"Osteopetrosis: genetics, treatment and new insights into osteoclast function","volume":"9","author":"Sobacchi","year":"2013","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"2019041201353688000_B8","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/j.tripleo.2009.08.043","article-title":"Gorham-Stout syndrome: a rare clinical entity and review of literature","volume":"109","author":"Gondivkar","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endodont"},{"issue":"4","key":"2019041201353688000_B9","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1210\/jc.2003-031055","article-title":"Decreased bone turnover and deterioration of bone structure in two cases of pycnodysostosis","volume":"89","author":"Fratzl-Zelman","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"18","key":"2019041201353688000_B10","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.1073\/pnas.87.18.7260","article-title":"Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells","volume":"87","author":"Udagawa","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041201353688000_B11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev.immunol.25.022106.141631","article-title":"The multiple roles of osteoclasts in host defense: bone remodeling and hematopoietic stem cell mobilization","volume":"25","author":"Kollet","year":"2007","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"2019041201353688000_B12","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2019041201353688000_B13","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1073\/pnas.97.4.1566","article-title":"RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism","volume":"97","author":"Li","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6937","key":"2019041201353688000_B14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"issue":"5184","key":"2019041201353688000_B15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1126\/science.7939685","article-title":"c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling","volume":"266","author":"Grigoriadis","year":"1994","journal-title":"Science"},{"issue":"6","key":"2019041201353688000_B16","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":"Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts","volume":"3","author":"Takayanagi","year":"2002","journal-title":"Dev Cell"},{"issue":"7","key":"2019041201353688000_B17","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1073\/pnas.072071099","article-title":"Mitf and Tfe3, two members of the Mitf-Tfe family of bHLH-Zip transcription factors, have important but functionally redundant roles in osteoclast development","volume":"99","author":"Steingrimsson","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"2019041201353688000_B18","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/nm.2452","article-title":"Evidence for osteocyte regulation of bone homeostasis through RANKL expression","volume":"17","author":"Nakashima","year":"2011","journal-title":"Nat Med"},{"issue":"4","key":"2019041201353688000_B19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s007740070018","article-title":"Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis","volume":"18","author":"Tsurukai","year":"2000","journal-title":"J Bone Miner Metab"},{"issue":"10","key":"2019041201353688000_B20","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/nm.2448","article-title":"Matrix-embedded cells control osteoclast formation","volume":"17","author":"Xiong","year":"2011","journal-title":"Nat Med"},{"issue":"3","key":"2019041201353688000_B21","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cmet.2014.07.011","article-title":"Mitochondrial complex I activity suppresses inflammation and enhances bone resorption by shifting macrophage-osteoclast polarization","volume":"20","author":"Jin","year":"2014","journal-title":"Cell Metab"},{"issue":"2","key":"2019041201353688000_B22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tem.2013.10.001","article-title":"Effects of bioactive lipids and lipoproteins on bone","volume":"25","author":"Tintut","year":"2014","journal-title":"Trends Endocrinol Metab"},{"key":"2019041201353688000_B23","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1038\/ncomms4773","article-title":"FoxO proteins restrain osteoclastogenesis and bone resorption by attenuating H2O2 accumulation","volume":"5","author":"Bartell","year":"2014","journal-title":"Nat Commun"},{"issue":"5484","key":"2019041201353688000_B24","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.289.5484.1501","article-title":"The osteoblast: a sophisticated fibroblast under central surveillance","volume":"289","author":"Ducy","year":"2000","journal-title":"Science"},{"key":"2019041201353688000_B25","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1146\/annurev.cellbio.042308.113308","article-title":"Genetic control of bone formation","volume":"25","author":"Karsenty","year":"2009","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2019041201353688000_B26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-pathol-011110-130203","article-title":"Disorders of bone remodeling","volume":"6","author":"Feng","year":"2011","journal-title":"Annu Rev Pathol"},{"issue":"2","key":"2019041201353688000_B27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"issue":"3","key":"2019041201353688000_B28","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1210\/endo.139.3.5837","article-title":"Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG\/OCIF inhibits osteoclastogenesis in vitro","volume":"139","author":"Yasuda","year":"1998","journal-title":"Endocrinology"},{"issue":"2","key":"2019041201353688000_B29","first-page":"295","article-title":"The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor \u03baB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells","volume":"26","author":"Kwan Tat","year":"2008","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"2019041201353688000_B30","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jama.292.4.490","article-title":"Clinical implications of the osteoprotegerin\/RANKL\/RANK system for bone and vascular diseases","volume":"292","author":"Hofbauer","year":"2004","journal-title":"JAMA"},{"issue":"4854","key":"2019041201353688000_B31","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1126\/science.3283939","article-title":"The steroid and thyroid hormone receptor superfamily","volume":"240","author":"Evans","year":"1988","journal-title":"Science"},{"issue":"6","key":"2019041201353688000_B32","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","article-title":"The nuclear receptor superfamily: the second decade","volume":"83","author":"Mangelsdorf","year":"1995","journal-title":"Cell"},{"issue":"10","key":"2019041201353688000_B33","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0168-9525(01)02417-9","article-title":"How many nuclear hormone receptors are there in the human genome?","volume":"17","author":"Robinson-Rechavi","year":"2001","journal-title":"Trends Genet"},{"issue":"5548","key":"2019041201353688000_B34","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1126\/science.294.5548.1866","article-title":"Nuclear receptors and lipid physiology: opening the X-files","volume":"294","author":"Chawla","year":"2001","journal-title":"Science"},{"issue":"5","key":"2019041201353688000_B35","first-page":"689","article-title":"Orphan nuclear receptors: from gene to function","volume":"20","author":"Giguere","year":"1999","journal-title":"Endocr Rev"},{"issue":"6","key":"2019041201353688000_B36","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1073\/pnas.90.6.2160","article-title":"Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers","volume":"90","author":"Keller","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6602","key":"2019041201353688000_B37","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/383728a0","article-title":"An oxysterol signalling pathway mediated by the nuclear receptor LXR \u03b1","volume":"383","author":"Janowski","year":"1996","journal-title":"Nature"},{"issue":"3","key":"2019041201353688000_B38","first-page":"321","article-title":"Nuclear receptor coregulators: cellular and molecular biology","volume":"20","author":"McKenna","year":"1999","journal-title":"Endocr Rev"},{"issue":"2","key":"2019041201353688000_B39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1101\/gad.14.2.121","article-title":"The coregulator exchange in transcriptional functions of nuclear receptors","volume":"14","author":"Glass","year":"2000","journal-title":"Genes Dev"},{"issue":"6294","key":"2019041201353688000_B40","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/347645a0","article-title":"Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators","volume":"347","author":"Issemann","year":"1990","journal-title":"Nature"},{"issue":"4","key":"2019041201353688000_B41","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0092-8674(02)00641-4","article-title":"Combinatorial control of gene expression by nuclear receptors and coregulators","volume":"108","author":"McKenna","year":"2002","journal-title":"Cell"},{"issue":"4","key":"2019041201353688000_B42","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1124\/pr.58.4.5","article-title":"International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors","volume":"58","author":"Michalik","year":"2006","journal-title":"Pharmacol Rev"},{"issue":"5","key":"2019041201353688000_B43","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.tem.2012.03.001","article-title":"Thiazolidinediones and PPAR\u03b3 agonists: time for a reassessment","volume":"23","author":"Cariou","year":"2012","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"2019041201353688000_B44","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2337\/diabetes.47.4.507","article-title":"PPAR-\u03b3: adipogenic regulator and thiazolidinedione receptor","volume":"47","author":"Spiegelman","year":"1998","journal-title":"Diabetes"},{"issue":"5","key":"2019041201353688000_B45","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.tips.2005.03.003","article-title":"PPARs: therapeutic targets for metabolic disease","volume":"26","author":"Berger","year":"2005","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"2019041201353688000_B46","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00198-007-0477-y","article-title":"Skeletal consequences of thiazolidinedione therapy","volume":"19","author":"Grey","year":"2008","journal-title":"Osteoporos Int"},{"issue":"4","key":"2019041201353688000_B47","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s11914-010-0027-y","article-title":"Bone loss in diabetes: use of antidiabetic thiazolidinediones and secondary osteoporosis","volume":"8","author":"Lecka-Czernik","year":"2010","journal-title":"Curr Osteoporos Rep"},{"issue":"4","key":"2019041201353688000_B48","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1210\/jc.2007-0328","article-title":"Thiazolidinediones: new evidence of bone loss","volume":"92","author":"Schwartz","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019041201353688000_B49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1517\/14740338.7.1.69","article-title":"Effect of thiazolidinediones on skeletal health in women with type 2 diabetes","volume":"7","author":"Schwartz","year":"2008","journal-title":"Exp Opin Drug Safe"},{"issue":"1","key":"2019041201353688000_B50","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1210\/jc.2009-0572","article-title":"Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes","volume":"95","author":"Zinman","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041201353688000_B51","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bone.2014.08.010","article-title":"Risk of fracture with thiazolidinediones: an updated meta-analysis of randomized clinical trials","volume":"68","author":"Zhu","year":"2014","journal-title":"Bone"},{"issue":"10","key":"2019041201353688000_B52","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/dom.12099","article-title":"Effect of pioglitazone on body composition and bone density in subjects with prediabetes in the ACT NOW trial","volume":"15","author":"Bray","year":"2013","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"2019041201353688000_B53","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrendo.2010.155","article-title":"PPAR\u03b3: a circadian transcription factor in adipogenesis and osteogenesis","volume":"6","author":"Kawai","year":"2010","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"2019041201353688000_B54","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.tem.2010.08.006","article-title":"PPAR\u03b3 in bone homeostasis","volume":"21","author":"Wan","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"2019041201353688000_B55","doi-asserted-by":"crossref","first-page":"867180","DOI":"10.1155\/2011\/867180","article-title":"Thiazolidinediones on PPAR\u03b3: the roles in bone remodeling","volume":"2011","author":"Wei","year":"2011","journal-title":"PPAR Res"},{"issue":"6","key":"2019041201353688000_B56","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1172\/JCI200419900","article-title":"PPAR\u03b3 insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors","volume":"113","author":"Akune","year":"2004","journal-title":"J Clin Invest"},{"issue":"4","key":"2019041201353688000_B57","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S1097-2765(00)80209-9","article-title":"PPAR \u03b3 is required for placental, cardiac, and adipose tissue development","volume":"4","author":"Barak","year":"1999","journal-title":"Mol Cell"},{"issue":"10","key":"2019041201353688000_B58","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/sj.embor.7400254","article-title":"Enhanced bone formation in lipodystrophic PPAR\u03b3(hyp\/hyp) mice relocates haematopoiesis to the spleen","volume":"5","author":"Cock","year":"2004","journal-title":"EMBO Rep"},{"issue":"4","key":"2019041201353688000_B59","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1097-2765(00)80210-5","article-title":"PPAR \u03b3 mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance","volume":"4","author":"Kubota","year":"1999","journal-title":"Mol Cell"},{"issue":"4","key":"2019041201353688000_B60","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1097-2765(00)80211-7","article-title":"PPAR \u03b3 is required for the differentiation of adipose tissue in vivo and in vitro","volume":"4","author":"Rosen","year":"1999","journal-title":"Mol Cell"},{"issue":"28","key":"2019041201353688000_B61","doi-asserted-by":"crossref","first-page":"23517","DOI":"10.1074\/jbc.M111.324814","article-title":"Thiazolidinediones induce osteocyte apoptosis by a G protein-coupled receptor 40-dependent mechanism","volume":"287","author":"Mieczkowska","year":"2012","journal-title":"J Biol Chem"},{"issue":"12","key":"2019041201353688000_B62","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/nm1672","article-title":"PPAR-\u03b3 regulates osteoclastogenesis in mice","volume":"13","author":"Wan","year":"2007","journal-title":"Nat Med"},{"issue":"4","key":"2019041201353688000_B63","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.bone.2006.04.008","article-title":"Surface-specific effects of a PPAR\u03b3 agonist, darglitazone, on bone in mice","volume":"39","author":"Li","year":"2006","journal-title":"Bone"},{"issue":"23","key":"2019041201353688000_B64","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1128\/MCB.05979-11","article-title":"Osteoclast progenitors reside in the peroxisome proliferator-activated receptor \u03b3-expressing bone marrow cell population","volume":"31","author":"Wei","year":"2011","journal-title":"Mol Cell Biol"},{"issue":"23","key":"2019041201353688000_B65","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1128\/MCB.05980-11","article-title":"Biphasic and dosage-dependent regulation of osteoclastogenesis by \u03b2-catenin","volume":"31","author":"Wei","year":"2011","journal-title":"Mol Cell Biol"},{"issue":"6","key":"2019041201353688000_B66","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.cmet.2010.04.015","article-title":"PGC1\u03b2 mediates PPAR\u03b3 activation of osteoclastogenesis and rosiglitazone-induced bone loss","volume":"11","author":"Wei","year":"2010","journal-title":"Cell Metab"},{"issue":"3","key":"2019041201353688000_B67","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nm.1910","article-title":"Coordination of PGC-1\u03b2 and iron uptake in mitochondrial biogenesis and osteoclast activation","volume":"15","author":"Ishii","year":"2009","journal-title":"Nat Med"},{"issue":"7515","key":"2019041201353688000_B68","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature13375","article-title":"miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2","volume":"512","author":"Krzeszinski","year":"2014","journal-title":"Nature"},{"issue":"6","key":"2019041201353688000_B69","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1210\/en.2006-1587","article-title":"Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone","volume":"148","author":"Lazarenko","year":"2007","journal-title":"Endocrinology"},{"issue":"1","key":"2019041201353688000_B70","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00774-007-0787-3","article-title":"Bone marrow stromal cell lines having high potential for osteoclast-supporting activity express PPARgamma1 and show high potential for differentiation into adipocytes","volume":"26","author":"Takagi","year":"2008","journal-title":"J Bone Miner Metab"},{"issue":"11","key":"2019041201353688000_B71","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1210\/endo.140.11.7116","article-title":"Thiazolidinediones inhibit osteoclast-like cell formation and bone resorption in vitro","volume":"140","author":"Okazaki","year":"1999","journal-title":"Endocrinology"},{"issue":"1","key":"2019041201353688000_B72","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bone.2006.07.029","article-title":"PPAR agonists modulate human osteoclast formation and activity in vitro","volume":"40","author":"Chan","year":"2007","journal-title":"Bone"},{"issue":"2","key":"2019041201353688000_B73","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10059-012-2240-z","article-title":"The effects of rosiglitazone on osteoblastic differentiation, osteoclast formation and bone resorption","volume":"33","author":"Cho","year":"2012","journal-title":"Mol Cell"},{"issue":"7","key":"2019041201353688000_B74","doi-asserted-by":"crossref","first-page":"e102706","DOI":"10.1371\/journal.pone.0102706","article-title":"Molecular mechanism of thiazolidinedione-mediated inhibitory effects on osteoclastogenesis","volume":"9","author":"Zhao","year":"2014","journal-title":"PloS One"},{"issue":"10","key":"2019041201353688000_B75","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.intimp.2009.06.002","article-title":"PPAR-\u03b3 agonist rosiglitazone prevents inflammatory periodontal bone loss by inhibiting osteoclastogenesis","volume":"9","author":"Hassumi","year":"2009","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"2019041201353688000_B76","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bone.2007.11.016","article-title":"Activation of peroxisome proliferator-activated receptor \u03b3 inhibits TNF-\u03b1-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression","volume":"42","author":"Hounoki","year":"2008","journal-title":"Bone"},{"issue":"6","key":"2019041201353688000_B77","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/SHK.0b013e3181cc0738","article-title":"Thiazolidinediones inhibit TNF-alpha-mediated osteoclast differentiation of RAW264.7 macrophages and mouse bone marrow cells through downregulation of NFATc1","volume":"33","author":"Yang","year":"2010","journal-title":"Shock"},{"issue":"7305","key":"2019041201353688000_B78","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature09291","article-title":"Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPAR\u03b3 by Cdk5","volume":"466","author":"Choi","year":"2010","journal-title":"Nature"},{"issue":"7365","key":"2019041201353688000_B79","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature10383","article-title":"Antidiabetic actions of a non-agonist PPAR\u03b3 ligand blocking Cdk5-mediated phosphorylation","volume":"477","author":"Choi","year":"2011","journal-title":"Nature"},{"issue":"38","key":"2019041201353688000_B80","doi-asserted-by":"crossref","first-page":"26618","DOI":"10.1074\/jbc.M114.566794","article-title":"A novel non-agonist peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) ligand UHC1 blocks PPAR\u03b3 phosphorylation by cyclin-dependent kinase 5 (CDK5) and improves insulin sensitivity","volume":"289","author":"Choi","year":"2014","journal-title":"J Biol Chem"},{"issue":"5","key":"2019041201353688000_B81","doi-asserted-by":"crossref","first-page":"e96323","DOI":"10.1371\/journal.pone.0096323","article-title":"Partial agonist, telmisartan, maintains PPAR\u03b3 serine 112 phosphorylation, and does not affect osteoblast differentiation and bone mass","volume":"9","author":"Kolli","year":"2014","journal-title":"PloS One"},{"issue":"5","key":"2019041201353688000_B82","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nm.3159","article-title":"PPAR\u03b3 signaling and metabolism: the good, the bad and the future","volume":"19","author":"Ahmadian","year":"2013","journal-title":"Nat Med"},{"issue":"11","key":"2019041201353688000_B83","doi-asserted-by":"crossref","first-page":"8126","DOI":"10.1074\/jbc.275.11.8126","article-title":"Cloning and function of rabbit peroxisome proliferator-activated receptor \u03b4\/\u03b2 in mature osteoclasts","volume":"275","author":"Mano","year":"2000","journal-title":"J Biol Chem"},{"issue":"5","key":"2019041201353688000_B84","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/nm.3146","article-title":"PPAR\u03b2\/\u03b4 governs Wnt signaling and bone turnover","volume":"19","author":"Scholtysek","year":"2013","journal-title":"Nat Med"},{"issue":"9","key":"2019041201353688000_B85","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1161\/ATVBAHA.112.247890","article-title":"Lipid effects of peroxisome proliferator-activated receptor-\u03b4 agonist GW501516 in subjects with low high-density lipoprotein cholesterol: characteristics of metabolic syndrome","volume":"32","author":"Olson","year":"2012","journal-title":"Arterioscl Thromb Vasc Biol"},{"issue":"3","key":"2019041201353688000_B86","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1677\/jme.0.0310349","article-title":"Estrogen receptor-related receptors: orphan receptors desperately seeking a ligand","volume":"31","author":"Horard","year":"2003","journal-title":"J Mol Endocrinol"},{"issue":"6151","key":"2019041201353688000_B87","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/331091a0","article-title":"Identification of a new class of steroid hormone receptors","volume":"331","author":"Giguere","year":"1988","journal-title":"Nature"},{"issue":"10","key":"2019041201353688000_B88","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.tem.2010.06.008","article-title":"ERR receptors as potential targets in osteoporosis","volume":"21","author":"Gallet","year":"2010","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"2019041201353688000_B89","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1210\/er.2008-0017","article-title":"Transcriptional control of energy homeostasis by the estrogen-related receptors","volume":"29","author":"Giguere","year":"2008","journal-title":"Endocr Rev"},{"issue":"22","key":"2019041201353688000_B90","doi-asserted-by":"crossref","first-page":"7947","DOI":"10.1128\/MCB.23.22.7947-7956.2003","article-title":"Reduced fat mass in mice lacking orphan nuclear receptor estrogen-related receptor \u03b1","volume":"23","author":"Luo","year":"2003","journal-title":"Mol Cell Biol"},{"issue":"8","key":"2019041201353688000_B91","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.tem.2008.07.005","article-title":"ERR\u03b1: a metabolic function for the oldest orphan","volume":"19","author":"Villena","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"2019041201353688000_B92","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1677\/erc.1.01292","article-title":"Estrogen-related receptor \u03b1 as a therapeutic target in cancer","volume":"13","author":"Stein","year":"2006","journal-title":"Endocr Relat Cancer"},{"issue":"13","key":"2019041201353688000_B93","doi-asserted-by":"crossref","first-page":"4670","DOI":"10.1158\/0008-5472.CAN-04-0250","article-title":"Estrogen-related receptor \u03b1 in human breast carcinoma as a potent prognostic factor","volume":"64","author":"Suzuki","year":"2004","journal-title":"Cancer Res"},{"issue":"17","key":"2019041201353688000_B94","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1073\/pnas.0401401101","article-title":"Err\u03b1 and Gabpa\/b specify PGC-1\u03b1-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle","volume":"101","author":"Mootha","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"15","key":"2019041201353688000_B95","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1101\/gad.1553007","article-title":"Nuclear receptor ERR \u03b1 and coactivator PGC-1 \u03b2 are effectors of IFN-\u03b3-induced host defense","volume":"21","author":"Sonoda","year":"2007","journal-title":"Genes Dev"},{"issue":"10","key":"2019041201353688000_B96","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1210\/en.2009-0121","article-title":"Absence of estrogen receptor-related-\u03b1 increases osteoblastic differentiation and cancellous bone mineral density","volume":"150","author":"Delhon","year":"2009","journal-title":"Endocrinology"},{"issue":"11","key":"2019041201353688000_B97","doi-asserted-by":"crossref","first-page":"e7942","DOI":"10.1371\/journal.pone.0007942","article-title":"Absence of ERR\u03b1 in female mice confers resistance to bone loss induced by age or estrogen-deficiency","volume":"4","author":"Teyssier","year":"2009","journal-title":"PloS One"},{"issue":"9","key":"2019041201353688000_B98","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1210\/en.2002-220095","article-title":"Estrogen receptor-related receptor \u03b1 impinges on the estrogen axis in bone: potential function in osteoporosis","volume":"143","author":"Bonnelye","year":"2002","journal-title":"Endocrinology"},{"issue":"6","key":"2019041201353688000_B99","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1677\/JME-10-0024","article-title":"Involvement of the orphan nuclear estrogen receptor-related receptor \u03b1 in osteoclast adhesion and transmigration","volume":"45","author":"Bonnelye","year":"2010","journal-title":"J Mol Endocrinol"},{"issue":"5","key":"2019041201353688000_B100","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1172\/JCI9794","article-title":"Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXR\u03b2-deficient mice","volume":"107","author":"Alberti","year":"2001","journal-title":"J Clin Invest"},{"issue":"11","key":"2019041201353688000_B101","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1073\/pnas.112059299","article-title":"Synthetic LXR ligand inhibits the development of atherosclerosis in mice","volume":"99","author":"Joseph","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2019041201353688000_B102","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1194\/jlr.M800376-JLR200","article-title":"Synthetic LXR agonist attenuates plaque formation in apoE\u2212\/\u2212 mice without inducing liver steatosis and hypertriglyceridemia","volume":"50","author":"Kratzer","year":"2009","journal-title":"J Lipid Res"},{"issue":"9","key":"2019041201353688000_B103","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1073\/pnas.0830671100","article-title":"Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue","volume":"100","author":"Laffitte","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2019041201353688000_B104","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nm820","article-title":"Reciprocal regulation of inflammation and lipid metabolism by liver X receptors","volume":"9","author":"Joseph","year":"2003","journal-title":"Nat Med"},{"issue":"21","key":"2019041201353688000_B105","doi-asserted-by":"crossref","first-page":"7686","DOI":"10.1158\/0008-5472.CAN-04-2332","article-title":"Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells","volume":"64","author":"Fukuchi","year":"2004","journal-title":"Cancer Res"},{"issue":"13","key":"2019041201353688000_B106","doi-asserted-by":"crossref","first-page":"6482","DOI":"10.1158\/0008-5472.CAN-06-0632","article-title":"Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist","volume":"66","author":"Chuu","year":"2006","journal-title":"Cancer Res"},{"issue":"6","key":"2019041201353688000_B107","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1074\/jbc.M411420200","article-title":"The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease","volume":"280","author":"Koldamova","year":"2005","journal-title":"J Biol Chem"},{"issue":"38","key":"2019041201353688000_B108","doi-asserted-by":"crossref","first-page":"33084","DOI":"10.1074\/jbc.M111.235937","article-title":"Activation of liver X receptor (LXR) inhibits receptor activator of nuclear factor \u03baB ligand (RANKL)-induced osteoclast differentiation in an LXR\u03b2-dependent mechanism","volume":"286","author":"Remen","year":"2011","journal-title":"J Biol Chem"},{"issue":"12","key":"2019041201353688000_B109","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1002\/jbmr.1702","article-title":"Liver X receptors orchestrate osteoblast\/osteoclast crosstalk and counteract pathologic bone loss","volume":"27","author":"Kleyer","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2019041201353688000_B110","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1189\/jlb.1112601","article-title":"Liver X receptor activation inhibits osteoclastogenesis by suppressing NF-\u03baB activity and c-Fos induction and prevents inflammatory bone loss in mice","volume":"94","author":"Kim","year":"2013","journal-title":"J Leukocyte Biol"},{"issue":"1","key":"2019041201353688000_B111","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1189\/jlb.0712339","article-title":"Activation of the liver X receptor-\u03b2 potently inhibits osteoclastogenesis from lipopolysaccharide-exposed bone marrow-derived macrophages","volume":"93","author":"Robertson Remen","year":"2013","journal-title":"J Leukocyte Biol"},{"issue":"8","key":"2019041201353688000_B112","first-page":"1471","article-title":"Retinoic acid. A key molecule for eye and photoreceptor development","volume":"38","author":"Hyatt","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"2019041201353688000_B113","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.cell.2008.09.002","article-title":"Retinoic acid synthesis and signaling during early organogenesis","volume":"134","author":"Duester","year":"2008","journal-title":"Cell"},{"issue":"7","key":"2019041201353688000_B114","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg2340","article-title":"Retinoic acid in development: towards an integrated view","volume":"9","author":"Niederreither","year":"2008","journal-title":"Nat Rev Genet"},{"key":"2019041201353688000_B115","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1196\/annals.1443.017","article-title":"Retinoic acid in the immune system","volume":"1143","author":"Pino-Lagos","year":"2008","journal-title":"Ann NY Acad Sci"},{"issue":"1","key":"2019041201353688000_B116","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.287.1.47","article-title":"Vitamin A intake and hip fractures among postmenopausal women","volume":"287","author":"Feskanich","year":"2002","journal-title":"JAMA"},{"issue":"8","key":"2019041201353688000_B117","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1359\/jbmr.2002.17.8.1349","article-title":"Retinol intake and bone mineral density in the elderly: the Rancho Bernardo Study","volume":"17","author":"Promislow","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2019041201353688000_B118","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1056\/NEJMoa021171","article-title":"Serum retinol levels and the risk of fracture","volume":"348","author":"Michaelsson","year":"2003","journal-title":"N Engl J Med"},{"issue":"10","key":"2019041201353688000_B119","doi-asserted-by":"crossref","first-page":"770","DOI":"10.7326\/0003-4819-129-10-199811150-00003","article-title":"Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture","volume":"129","author":"Melhus","year":"1998","journal-title":"Ann Intern Med"},{"issue":"10","key":"2019041201353688000_B120","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1753-4887.2007.tb00268.x","article-title":"Vitamin A: is it a risk factor for osteoporosis and bone fracture?","volume":"65","author":"Ribaya-Mercado","year":"2007","journal-title":"Nutr Rev"},{"issue":"1","key":"2019041201353688000_B121","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3945\/ajcn.2008.26451","article-title":"Vitamin A and retinol intakes and the risk of fractures among participants of the Women's Health Initiative Observational Study","volume":"89","author":"Caire-Juvera","year":"2009","journal-title":"Am J Clin Nutr"},{"issue":"12","key":"2019041201353688000_B122","doi-asserted-by":"crossref","first-page":"7135","DOI":"10.1073\/pnas.1231422100","article-title":"Retinoid activation of retinoic acid receptor but not retinoid X receptor is sufficient to rescue lethal defect in retinoic acid synthesis","volume":"100","author":"Mic","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"36","key":"2019041201353688000_B123","doi-asserted-by":"crossref","first-page":"31425","DOI":"10.1074\/jbc.M111.247734","article-title":"Retinoids stimulate periosteal bone resorption by enhancing the protein RANKL, a response inhibited by monomeric glucocorticoid receptor","volume":"286","author":"Conaway","year":"2011","journal-title":"J Biol Chem"},{"issue":"6","key":"2019041201353688000_B124","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1210\/endo-122-6-2933","article-title":"Effects of hypervitaminosis A on the bone and mineral metabolism of the rat","volume":"122","author":"Hough","year":"1988","journal-title":"Endocrinology"},{"issue":"8","key":"2019041201353688000_B125","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/jbmr.5650060806","article-title":"Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro","volume":"6","author":"Lakkakorpi","year":"1991","journal-title":"J Bone Miner Res"},{"issue":"Pt 3","key":"2019041201353688000_B126","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1042\/bj3090721","article-title":"Retinoic acid directly stimulates osteoclastic bone resorption and gene expression of cathepsin K\/OC-2","volume":"309","author":"Saneshige","year":"1995","journal-title":"Biochem J"},{"issue":"1","key":"2019041201353688000_B127","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/8756-3282(90)90072-7","article-title":"Retinoic acid and 1,25-dihydroxyvitamin D3 stimulate osteoclast formation by different mechanisms","volume":"11","author":"Scheven","year":"1990","journal-title":"Bone"},{"issue":"2","key":"2019041201353688000_B128","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0306-3623(91)90450-K","article-title":"Effects of retinoic acid on bone formation and resorption in cultured mouse calvaria","volume":"22","author":"Togari","year":"1991","journal-title":"Gen Pharmacol"},{"issue":"10","key":"2019041201353688000_B129","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1096\/fj.09-132548","article-title":"Retinoids inhibit differentiation of hematopoietic osteoclast progenitors","volume":"23","author":"Conaway","year":"2009","journal-title":"FASEB J"},{"issue":"10","key":"2019041201353688000_B130","doi-asserted-by":"crossref","first-page":"e13305","DOI":"10.1371\/journal.pone.0013305","article-title":"Retinoic acid increases proliferation of human osteoclast progenitors and inhibits RANKL-stimulated osteoclast differentiation by suppressing RANK","volume":"5","author":"Hu","year":"2010","journal-title":"PloS One"},{"issue":"6","key":"2019041201353688000_B131","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s00774-011-0261-0","article-title":"Retinoic acid inhibits NFATc1 expression and osteoclast differentiation","volume":"29","author":"Balkan","year":"2011","journal-title":"J Bone Miner Metab"},{"issue":"2","key":"2019041201353688000_B132","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.bone.2004.11.006","article-title":"Retinoid-induced bone thinning is caused by subperiosteal osteoclast activity in adult rodents","volume":"36","author":"Kneissel","year":"2005","journal-title":"Bone"},{"issue":"3","key":"2019041201353688000_B133","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1210\/edrv.20.3.0370","article-title":"Estrogen receptor null mice: what have we learned and where will they lead us?","volume":"20","author":"Couse","year":"1999","journal-title":"Endocr Rev"},{"issue":"5484","key":"2019041201353688000_B134","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1126\/science.289.5484.1508","article-title":"Therapeutic approaches to bone diseases","volume":"289","author":"Rodan","year":"2000","journal-title":"Science"},{"issue":"2","key":"2019041201353688000_B135","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1677\/joe.0.1740167","article-title":"Estrogen receptor specificity for the effects of estrogen in ovariectomized mice","volume":"174","author":"Lindberg","year":"2002","journal-title":"J Endocrinol"},{"issue":"5","key":"2019041201353688000_B136","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1359\/jbmr.1998.13.5.763","article-title":"A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men","volume":"13","author":"Riggs","year":"1998","journal-title":"J Bone Miner Res"},{"issue":"16","key":"2019041201353688000_B137","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1056\/NEJM199410203311604","article-title":"Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man","volume":"331","author":"Smith","year":"1994","journal-title":"N Engl J Med"},{"issue":"10","key":"2019041201353688000_B138","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.1073\/pnas.97.10.5474","article-title":"Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice","volume":"97","author":"Vidal","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"2019041201353688000_B139","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nrendo.2013.179","article-title":"The role of estrogen and androgen receptors in bone health and disease","volume":"9","author":"Manolagas","year":"2013","journal-title":"Nat Rev Endocrinol"},{"issue":"5066","key":"2019041201353688000_B140","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.1621100","article-title":"Increased osteoclast development after estrogen loss: mediation by interleukin-6","volume":"257","author":"Jilka","year":"1992","journal-title":"Science"},{"issue":"2","key":"2019041201353688000_B141","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1210\/me.2009-0354","article-title":"The estrogen receptor-\u03b1 in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone","volume":"24","author":"Martin-Millan","year":"2010","journal-title":"Mol Endocrinol"},{"issue":"8","key":"2019041201353688000_B142","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI200317215","article-title":"Role of RANK ligand in mediating increased bone resorption in early postmenopausal women","volume":"111","author":"Eghbali-Fatourechi","year":"2003","journal-title":"J Clin Invest"},{"issue":"10","key":"2019041201353688000_B143","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1172\/JCI11066","article-title":"Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-\u03b1","volume":"106","author":"Cenci","year":"2000","journal-title":"J Clin Invest"},{"issue":"11","key":"2019041201353688000_B144","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1359\/jbmr.060726","article-title":"T lymphocyte-deficient mice lose trabecular bone mass with ovariectomy","volume":"21","author":"Lee","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"35","key":"2019041201353688000_B145","doi-asserted-by":"crossref","first-page":"29851","DOI":"10.1074\/jbc.M112.377945","article-title":"Receptor activator of nuclear factor \u03baB ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss","volume":"287","author":"Onal","year":"2012","journal-title":"J Biol Chem"},{"issue":"9","key":"2019041201353688000_B146","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1210\/endo.140.9.7131","article-title":"Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"issue":"14","key":"2019041201353688000_B147","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.1073\/pnas.130200197","article-title":"Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression","volume":"97","author":"Shevde","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2019041201353688000_B148","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1210\/er.2009-0024","article-title":"From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis","volume":"31","author":"Manolagas","year":"2010","journal-title":"Endocr Rev"},{"issue":"10","key":"2019041201353688000_B149","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/nm1096-1132","article-title":"Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-\u03b2","volume":"2","author":"Hughes","year":"1996","journal-title":"Nat Med"},{"issue":"4","key":"2019041201353688000_B150","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1084\/jem.186.4.489","article-title":"Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts","volume":"186","author":"Kameda","year":"1997","journal-title":"J Exp Med"},{"issue":"5","key":"2019041201353688000_B151","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2007.07.025","article-title":"Estrogen prevents bone loss via estrogen receptor \u03b1 and induction of Fas ligand in osteoclasts","volume":"130","author":"Nakamura","year":"2007","journal-title":"Cell"},{"issue":"3","key":"2019041201353688000_B152","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/sj.emboj.7601984","article-title":"Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival","volume":"27","author":"Krum","year":"2008","journal-title":"EMBO J"},{"issue":"2","key":"2019041201353688000_B153","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jbmr.1747","article-title":"ER\u03b1 signaling regulates MMP3 expression to induce FasL cleavage and osteoclast apoptosis","volume":"28","author":"Garcia","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2019041201353688000_B154","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/jbmr.1754","article-title":"Estrogen receptor-\u03b1 is required for the osteogenic response to mechanical loading in a ligand-independent manner involving its activation function 1 but not 2","volume":"28","author":"Windahl","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2019041201353688000_B155","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S8756-3282(01)00643-3","article-title":"Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-\u03b2 in bone remodeling in females but not in males","volume":"30","author":"Sims","year":"2002","journal-title":"Bone"},{"issue":"8","key":"2019041201353688000_B156","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1210\/en.2010-0080","article-title":"The endogenous selective estrogen receptor modulator 27-hydroxycholesterol is a negative regulator of bone homeostasis","volume":"151","author":"DuSell","year":"2010","journal-title":"Endocrinology"},{"issue":"12","key":"2019041201353688000_B157","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1210\/en.2011-1298","article-title":"The oxysterol, 27-hydroxycholesterol, links cholesterol metabolism to bone homeostasis through its actions on the estrogen and liver X receptors","volume":"152","author":"Nelson","year":"2011","journal-title":"Endocrinology"},{"issue":"1","key":"2019041201353688000_B158","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bone.2012.11.011","article-title":"The molecular mechanisms underlying the pharmacological actions of estrogens, SERMs and oxysterols: implications for the treatment and prevention of osteoporosis","volume":"53","author":"Nelson","year":"2013","journal-title":"Bone"},{"key":"2019041201353688000_B159","first-page":"12S","article-title":"Prevention of osteoporosis: treatment of estradiol deficiency","volume":"72","author":"Ettinger","year":"1988","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2019041201353688000_B160","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1124\/pr.109.002071","article-title":"Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines","volume":"62","author":"Gillies","year":"2010","journal-title":"Pharmacol Rev"},{"issue":"5","key":"2019041201353688000_B161","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1096\/fasebj.10.5.8621060","article-title":"The vascular protective effects of estrogen","volume":"10","author":"Farhat","year":"1996","journal-title":"FASEB J"},{"issue":"3","key":"2019041201353688000_B162","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1210\/endo.138.3.4979","article-title":"Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors \u03b1 and \u03b2","volume":"138","author":"Kuiper","year":"1997","journal-title":"Endocrinology"},{"issue":"9","key":"2019041201353688000_B163","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJM199608293350907","article-title":"Endometrial carcinoma","volume":"335","author":"Rose","year":"1996","journal-title":"N Engl J Med"},{"issue":"9084","key":"2019041201353688000_B164","first-page":"1047","article-title":"yCollaborative Group on Hormonal Factors in Breast Cancer","volume":"350","author":"Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer","year":"1997","journal-title":"Lancet"},{"issue":"4","key":"2019041201353688000_B165","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1056\/NEJM200101253440407","article-title":"Estrogen and the risk of breast cancer","volume":"344","author":"Clemons","year":"2001","journal-title":"N Engl J Med"},{"issue":"5594","key":"2019041201353688000_B166","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1074935","article-title":"Reversal of bone loss in mice by nongenotropic signaling of sex steroids","volume":"298","author":"Kousteni","year":"2002","journal-title":"Science"},{"issue":"5","key":"2019041201353688000_B167","first-page":"719","article-title":"Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity","volume":"104","author":"Kousteni","year":"2001","journal-title":"Cell"},{"issue":"4","key":"2019041201353688000_B168","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1210\/me.2012-1368","article-title":"Non-nuclear-initiated actions of the estrogen receptor protect cortical bone mass","volume":"27","author":"Bartell","year":"2013","journal-title":"Mol Endocrinol"},{"issue":"4","key":"2019041201353688000_B169","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1359\/jbmr.081217","article-title":"Mineralization and bone resorption are regulated by the androgen receptor in male mice","volume":"24","author":"Chiang","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2019041201353688000_B170","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1210\/jcem.85.3.6428","article-title":"The contribution of testosterone to skeletal development and maintenance: lessons from the androgen insensitivity syndrome","volume":"85","author":"Marcus","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041201353688000_B171","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/MED.0b013e32835f7d04","article-title":"Novel insights in the regulation and mechanism of androgen action on bone","volume":"20","author":"Sinnesael","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"16","key":"2019041201353688000_B172","doi-asserted-by":"crossref","first-page":"9416","DOI":"10.1073\/pnas.1533500100","article-title":"Suppressive function of androgen receptor in bone resorption","volume":"100","author":"Kawano","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2019041201353688000_B173","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1359\/jbmr.061117","article-title":"Osteoblast deletion of exon 3 of the androgen receptor gene results in trabecular bone loss in adult male mice","volume":"22","author":"Notini","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"12","key":"2019041201353688000_B174","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1002\/jbmr.1713","article-title":"Androgen receptor (AR) in osteocytes is important for the maintenance of male skeletal integrity: evidence from targeted AR disruption in mouse osteocytes","volume":"27","author":"Sinnesael","year":"2012","journal-title":"J Bone Miner Res"},{"key":"2019041201353688000_B175","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1749-6632.2009.05013.x","article-title":"Clinical features associated with glucocorticoid receptor polymorphisms. An overview","volume":"1179","author":"Manenschijn","year":"2009","journal-title":"Ann NY Acad Sci"},{"issue":"3","key":"2019041201353688000_B176","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11926-011-0173-y","article-title":"Advances in glucocorticoid-induced osteoporosis","volume":"13","author":"den Uyl","year":"2011","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"2019041201353688000_B177","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1359\/jbmr.2001.16.1.97","article-title":"Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis","volume":"16","author":"Dalle Carbonare","year":"2001","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2019041201353688000_B178","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI2799","article-title":"Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone","volume":"102","author":"Weinstein","year":"1998","journal-title":"J Clin Invest"},{"issue":"5","key":"2019041201353688000_B179","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S8756-3282(01)00422-7","article-title":"Cortisol inhibits the differentiation and apoptosis of osteoblasts in culture","volume":"28","author":"Pereira","year":"2001","journal-title":"Bone"},{"issue":"6","key":"2019041201353688000_B180","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cmet.2010.05.005","article-title":"Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor","volume":"11","author":"Rauch","year":"2010","journal-title":"Cell Metab"},{"issue":"6","key":"2019041201353688000_B181","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.molmed.2012.04.005","article-title":"Glucocorticoid receptor signaling in bone cells","volume":"18","author":"Moutsatsou","year":"2012","journal-title":"Trends Mol Med"},{"issue":"10","key":"2019041201353688000_B182","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","article-title":"Glucocorticoid-induced osteoporosis: pathophysiology and therapy","volume":"18","author":"Canalis","year":"2007","journal-title":"Osteoporos Int"},{"issue":"1","key":"2019041201353688000_B183","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/jcb.21414","article-title":"Dexamethasone promotes osteoclastogenesis by inhibiting osteoprotegerin through multiple levels","volume":"103","author":"Kondo","year":"2008","journal-title":"J Cell Biochem"},{"issue":"10","key":"2019041201353688000_B184","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1210\/endo.140.10.7034","article-title":"Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"issue":"12","key":"2019041201353688000_B185","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1210\/en.2006-0459","article-title":"Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density","volume":"147","author":"Jia","year":"2006","journal-title":"Endocrinology"},{"issue":"1","key":"2019041201353688000_B186","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1210\/en.2010-0456","article-title":"Dissociation of osteogenic and immunological effects by the selective glucocorticoid receptor agonist, compound A, in human bone marrow stromal cells","volume":"152","author":"Rauner","year":"2011","journal-title":"Endocrinology"},{"issue":"11","key":"2019041201353688000_B187","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/jbmr.1688","article-title":"Selective glucocorticoid receptor modulation maintains bone mineral density in mice","volume":"27","author":"Thiele","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"8","key":"2019041201353688000_B188","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1172\/JCI0214538","article-title":"Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids","volume":"109","author":"Weinstein","year":"2002","journal-title":"J Clin Invest"},{"issue":"8","key":"2019041201353688000_B189","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1172\/JCI28084","article-title":"Glucocorticoids suppress bone formation via the osteoclast","volume":"116","author":"Kim","year":"2006","journal-title":"J Clin Invest"},{"key":"2019041201353688000_B190","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/bonekey.2014.17","article-title":"Vitamin D endocrine system and osteoclasts","volume":"3","author":"Takahashi","year":"2014","journal-title":"Bonekey Rep"},{"issue":"6460","key":"2019041201353688000_B191","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/367284a0","article-title":"Prediction of bone density from vitamin D receptor alleles","volume":"367","author":"Morrison","year":"1994","journal-title":"Nature"},{"issue":"2 Pt 2","key":"2019041201353688000_B192","first-page":"F157","article-title":"Vitamin D","volume":"277","author":"Brown","year":"1999","journal-title":"Am J Physiol"},{"issue":"4","key":"2019041201353688000_B193","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1152\/physrev.1998.78.4.1193","article-title":"Current understanding of the molecular actions of vitamin D","volume":"78","author":"Jones","year":"1998","journal-title":"Physiol Rev"},{"issue":"2","key":"2019041201353688000_B194","first-page":"156","article-title":"The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets","volume":"20","author":"Malloy","year":"1999","journal-title":"Endocr Rev"},{"key":"2019041201353688000_B195","doi-asserted-by":"crossref","first-page":"V105","DOI":"10.1359\/jbmr.07s210","article-title":"Vitamin D-resistant diseases","volume":"22","author":"Liberman","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"4886","key":"2019041201353688000_B196","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1126\/science.2849209","article-title":"Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets","volume":"242","author":"Hughes","year":"1988","journal-title":"Science"},{"issue":"2","key":"2019041201353688000_B197","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1172\/JCI119158","article-title":"Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness","volume":"99","author":"Malloy","year":"1997","journal-title":"J Clin Invest"},{"issue":"3\u20134","key":"2019041201353688000_B198","first-page":"73","article-title":"Molecular genetics of vitamin D-dependent hereditary rickets","volume":"57","author":"Kato","year":"2002","journal-title":"Horm Res"},{"key":"2019041201353688000_B199","first-page":"341","article-title":"Molecular cloning of (25-OH D)-1 \u03b1-hydroxylase: an approach to the understanding of vitamin D pseudo-deficiency","volume":"53","author":"Glorieux","year":"1998","journal-title":"Recent Prog Horm Res"},{"issue":"10","key":"2019041201353688000_B200","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJM199803053381004","article-title":"Inactivating mutations in the 25-hydroxyvitamin D3 1\u03b1-hydroxylase gene in patients with pseudovitamin D-deficiency rickets","volume":"338","author":"Kitanaka","year":"1998","journal-title":"N Engl J Med"},{"issue":"13","key":"2019041201353688000_B201","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1073\/pnas.131029498","article-title":"Targeted ablation of the 25-hydroxyvitamin D 1\u03b1-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction","volume":"98","author":"Panda","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"2019041201353688000_B202","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1210\/endo.142.7.8281","article-title":"Targeted inactivation of the 25-hydroxyvitamin D(3)-1\u03b1-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets","volume":"142","author":"Dardenne","year":"2001","journal-title":"Endocrinology"},{"issue":"18","key":"2019041201353688000_B203","doi-asserted-by":"crossref","first-page":"9831","DOI":"10.1073\/pnas.94.18.9831","article-title":"Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia","volume":"94","author":"Li","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2019041201353688000_B204","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/ng0897-391","article-title":"Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning","volume":"16","author":"Yoshizawa","year":"1997","journal-title":"Nat Genet"},{"issue":"10","key":"2019041201353688000_B205","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1210\/endo.139.10.6262","article-title":"Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice","volume":"139","author":"Li","year":"1998","journal-title":"Endocrinology"},{"issue":"1","key":"2019041201353688000_B206","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1210\/endo.142.1.8050","article-title":"Dietary phosphorus restriction reverses the impaired bone mineralization in vitamin D receptor knockout mice","volume":"142","author":"Masuyama","year":"2001","journal-title":"Endocrinology"},{"issue":"4","key":"2019041201353688000_B207","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1053\/j.gastro.2008.12.051","article-title":"Intestinal vitamin D receptor is required for normal calcium and bone metabolism in mice","volume":"136","author":"Xue","year":"2009","journal-title":"Gastroenterology"},{"issue":"5","key":"2019041201353688000_B208","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1172\/JCI45890","article-title":"Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization","volume":"122","author":"Lieben","year":"2012","journal-title":"J Clin Invest"},{"issue":"23","key":"2019041201353688000_B209","doi-asserted-by":"crossref","first-page":"8213","DOI":"10.1073\/pnas.82.23.8213","article-title":"1,25-Dihydroxyvitamin D3 causes formation of multinucleated cells with several osteoclast characteristics in cultures of primate marrow","volume":"82","author":"Roodman","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2019041201353688000_B210","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/jcb.10331","article-title":"Vitamin D and bone","volume":"88","author":"Suda","year":"2003","journal-title":"J Cell Biochem"},{"issue":"2","key":"2019041201353688000_B211","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1210\/endo.140.2.6673","article-title":"Stimulation of osteoclast formation by 1,25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: studies using VDR knockout mice","volume":"140","author":"Takeda","year":"1999","journal-title":"Endocrinology"},{"issue":"12","key":"2019041201353688000_B212","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1172\/JCI29463","article-title":"Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts","volume":"116","author":"Masuyama","year":"2006","journal-title":"J Clin Invest"},{"issue":"6","key":"2019041201353688000_B213","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM199202063260601","article-title":"Treatment of postmenopausal osteoporosis with calcitriol or calcium","volume":"326","author":"Tilyard","year":"1992","journal-title":"N Engl J Med"},{"issue":"4","key":"2019041201353688000_B214","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.bone.2011.07.011","article-title":"A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures\u2014a randomized, active comparator, double-blind study","volume":"49","author":"Matsumoto","year":"2011","journal-title":"Bone"},{"issue":"2","key":"2019041201353688000_B215","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/jbmr.555","article-title":"Daily administration of eldecalcitol (ED-71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone","volume":"27","author":"Harada","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"8","key":"2019041201353688000_B216","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S1043-2760(03)00144-9","article-title":"The molecular actions of thyroid hormone in bone","volume":"14","author":"Bassett","year":"2003","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"2019041201353688000_B217","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.abb.2010.06.021","article-title":"Thyroid and bone","volume":"503","author":"Gogakos","year":"2010","journal-title":"Arch Biochem Biophys"},{"issue":"326","key":"2019041201353688000_B218","doi-asserted-by":"crossref","first-page":"ra48","DOI":"10.1126\/scisignal.2004911","article-title":"Nongenomic thyroid hormone signaling occurs through a plasma membrane-localized receptor","volume":"7","author":"Kalyanaraman","year":"2014","journal-title":"Sci Signal"}],"container-title":["Molecular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/29\/2\/172\/8909156\/mend0172.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T16:33:36Z","timestamp":1650904416000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mend\/article\/29\/2\/172\/2556402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,1]]},"references-count":218,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/me.2014-1316","relation":{},"ISSN":["0888-8809","1944-9917"],"issn-type":[{"value":"0888-8809","type":"print"},{"value":"1944-9917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,1]]}}}